Cargando…
Three-Times Daily Ultrafractionated Radiation Therapy, A Novel and Promising Regimen for Glioblastoma Patients
Glioblastomas are considered to be one of the most radio resistant tumors. Despite new therapies, the prognosis of this disease remains dismal. Also, the mechanisms of radiation resistance in mammalian cells are more complex than once believed. Experimental studies have indicated that some human cel...
Autor principal: | Beauchesne, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875935/ https://www.ncbi.nlm.nih.gov/pubmed/24202441 http://dx.doi.org/10.3390/cancers5041199 |
Ejemplares similares
-
Clinical Studies on Ultrafractionated Chemoradiation: A Systematic Review
por: Scirocco, Erica, et al.
Publicado: (2021) -
Differential effects of radiation fractionation regimens on glioblastoma
por: McKelvey, Kelly J., et al.
Publicado: (2022) -
Insulin detemir in a twice daily insulin regimen versus a three times daily insulin regimen in the treatment of type 1 diabetes in children: A pilot randomized controlled trial
por: Ho, Josephine, et al.
Publicado: (2011) -
Daily Tracking of Glioblastoma Resection Cavity, Cerebral Edema, and Tumor Volume with MRI-Guided Radiation Therapy
por: Mehta, Shahil, et al.
Publicado: (2018) -
Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution
por: Azoulay, Melissa, et al.
Publicado: (2015)